Reshaping Vision Possibilities
Orasis Pharmaceuticals is an ophthalmic pharmaceutical company focused on near vision correction. They developed Qlosi (pilocarpine hydrochloride 0.4%), a preservative-free prescription eye drop FDA-approved in 2023 for the treatment of presbyopia in adults. The company targets the nearly 128 million Americans living with age-related blurry near vision as an alternative to reading glasses or surgery.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2024
Sep 2020
Jun 2018
Create a free account to see which investors have funded this company.
Create Free Account
Hinge Health is pioneering digital care programs for people with chronic musculoskeletal conditio...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Klick Health is a healthcare marketing and commercialization agency serving life sciences and pha...
